| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.02 |